Weight-loss drugs that target the hormone GLP-1 have rapidly reshaped the conversation around obesity, appetite and personal responsibility. But alongside the rise of powerful synthetic injectables, researchers are also exploring whether the body’s own appetite signals can be harnessed more naturally. At the heart of the debate is a simple question: are we eating too much because of weak willpower, or because of biology? As new approaches emerge, the challenge is to balance effectiveness, safety and long-term sustainability in tackling one of modern health’s most persistent problems. In this interview, Sarah Kennedy, founder of Calocurb, a New Zealand company which has developed a plant-based compound designed to naturally stimulate GLP-1, discusses the science of appetite control and how it compares to injectable drugs. --------------- Try Calocurb for yourself? Get a 10% discount HERE --------------- This podcast is supported by affiliate arrangements with a select number of companies. We have arranged discounts on certain products and receive a small commission on sales. The income helps to cover production costs and ensures that our interviews remain free for all to listen. Use code LLAMA for a 20 percent discount PartiQlar supplements Enhance your wellness journey with pure single ingredients. 15% DISCOUNT - use code: MASTERAGING15 Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you. If you have health concerns of any kind, or you are considering adopting a new diet or exercise regime, you should consult your doctor.